Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Marker for Asthma Identified at Oxford

11.02.2003


Researchers at Oxford University’s Wellcome Trust Centre for Human Genetics have located a variant form of a polynucleotide sequence in the MHC region of chromosome 6p and identified its association with an increased secretion of TNF. Potential applications for this discovery include the diagnosis of asthma in patients, or a predisposition to asthma, and a patients’ suitability for treatment with anti-TNF therapy.



Asthma is a disease in which the airways become inflamed leading to blockage and narrowing, with resultant symptoms including wheezing, coughing, shortness of breath and tightening of the chest. Asthma sufferers can be of any race, age or sex, and over 17 million people in the United States alone suffer from the disease.

Most asthma is initiated by an IgE mediated allergy (atopy) to inhaled environmental allergens, including pollen, air pollutants and irritants. The susceptibility to asthma is strongly familial, and is due to both genetic and environmental factors. The identification of other genetic factors will lead to further understanding of susceptibility to asthma and an ability to develop a pharmacogenomic approach to treatment, new therapeutic approaches to treat sub-groups of patients who will benefit most from them. Tumour necrosis factor (TNF) is a potent pro-inflammatory cytokine that is found in increased concentrations in asthmatic airways and in lavage fluid from asthmatic lungs.


The Oxford research team has found that unusual genetic variants in or linked to the TNF? gene are predictive of asthma and inhaled or oral steroid usage in asthmatic individuals. This exciting new technology may be used as a diagnostic tool, useful to predict the clinical course of disease or the response to particular treatments, as well as helping to develop new therapeutic strategies.

Isis Innovation, Oxford University’s technology transfer company, has filed a patent application (US 09/058,165, 20010007741) and is actively seeking licensees to develop and commercialise this technology.

Jennifer Johnson | alfa
Further information:
http://www.isis-innovation.com/licensing/146.html

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>